Dimethylformamide → HCID 54007382, compound
Reaction equation
[C:1]([O:5][C:6]([NH:8][C@H:9]([C:21]([OH:23])=O)[CH2:10][CH2:11][CH2:12][CH2:13][NH:14][CH:15]([C:17]([O:19][CH3:20])=[O:18])[CH3:16])=[O:7])([CH3:4])([CH3:3])[CH3:2].ON1C(=O)CCC1=O.C1(N=C=NC2CCCCC2)CCCCC1.CN(C=O)C>C(OCC)(=O)C>[C:1]([O:5][C:6]([NH:8][C@H:9]1[CH2:10][CH2:11][CH2:12][CH2:13][N:14]([CH:15]([C:17]([O:19][CH3:20])=[O:18])[CH3:16])[C:21]1=[O:23])=[O:7])([CH3:2])([CH3:3])[CH3:4]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Dissolve 4.76 g of the lysine derivative, 1.64 g. of N-hydroxysuccinimide and 3.24 g dicyclohexylcarbodiimide in 250 ml. of DMF. Store this reaction mixture at 0° C. for two days. Concentrate the reaction in vacuo and dissolve the residue in ethyl acetate. Filter and purify the product by silica gel chromatography. Isolate the purified 3-(S)-t-butoxycarbonylamino-1-(1-methoxycarbonylethyl)perhydroazepin-2-one.
Workup
- concentrationConcentrate
- customthe reaction in vacuo
- filtrationFilter
- custompurify the product by silica gel chromatography
Sources & evidence
- ORD record
- ord-21b1485c4a28469abf94607ed5f1db7b
- Source dataset
- uspto-grants-1987_07
- Patent number
- US04680392
Reaction notes
Loading…